Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000800396 | SCV000940109 | pathogenic | Qualitative or quantitative defects of dysferlin | 2024-10-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu1269Glyfs*7) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This variant is present in population databases (rs779407815, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with distal myopathy (PMID: 29997562). ClinVar contains an entry for this variant (Variation ID: 646166). For these reasons, this variant has been classified as Pathogenic. |
Athena Diagnostics | RCV001289421 | SCV001477223 | likely pathogenic | not provided | 2019-09-24 | criteria provided, single submitter | clinical testing | The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity. |
Revvity Omics, |
RCV001289421 | SCV002021830 | pathogenic | not provided | 2020-07-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003461123 | SCV004196534 | pathogenic | Miyoshi muscular dystrophy 1 | 2023-05-09 | criteria provided, single submitter | clinical testing |